Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Rhythm Biosciences Ltd has appointed Gavin Fox-Smith, a seasoned leader in the MedTech industry, as a Non-Executive Director, effective December 2, 2024. His vast experience and connections are expected to help the company achieve its commercialisation goals, particularly with its innovative cancer diagnostic technology. This strategic move signals potential growth as Rhythm aims to revolutionize bowel cancer detection globally.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.